Sarepta Therapeutics Inc. (SRPT)

NASDAQ: SRPT · Real-Time Price · USD

62.80

0.40 (0.64%)

At close: May 01, 2025, 3:59 PM

Sarepta Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	1.9B	1.24B	933.01M	701.89M	540.1M	380.83M	301.03M	154.58M	5.42M
Cost of Revenue	319.1M	150.34M	139.99M	97.05M	63.38M	56.59M	34.19M	7.35M	130K
Gross Profit	1.58B	1.09B	793.02M	604.84M	476.72M	324.25M	266.84M	147.23M	5.29M
Operating Income	218.08M	-267.82M	-536.2M	-449.71M	-564.16M	-522.32M	-343.63M	-171.64M	-266.73M
Interest Income	71.77M	85.97M	16.49M	354K	2.97M	7.24M	6.81M	1.81M	507K
Pretax Income	260.77M	-520.1M	-689.96M	-418.95M	-553.07M	-713.88M	-362.61M	-48.63M	-267.26M
Net Income	235.24M	-535.98M	-703.49M	-418.78M	-554.13M	-715.08M	-361.92M	-50.69M	-267.26M
Selling & General & Admin	557.87M	481.87M	451.42M	282.66M	317.88M	284.81M	207.76M	122.68M	83.75M
Research & Development	804.52M	877.39M	877.09M	771.18M	722.34M	560.91M	401.84M	166.71M	188.27M
Other Expenses	2.4M	1.56M	714K	706K	662K	849K	-656K	1.98M	n/a
Operating Expenses	1.36B	1.36B	1.33B	1.05B	1.04B	846.57M	610.47M	290.44M	272.02M
Interest Expense	18.39M	22.01M	53.25M	63.52M	59.95M	30.67M	33.71M	5.78M	1.89M
Selling & Marketing Expenses	n/a	28.6M	14.6M	7.7M	n/a	n/a	-2.22M	2.83M	2.55M
Cost & Expenses	1.68B	1.51B	1.47B	1.15B	1.1B	903.16M	644.66M	297.8M	272.15M
Income Tax Expense	25.54M	15.88M	13.53M	-168K	1.06M	1.2M	-692K	2.06M	-7.62M
Shares Outstanding (Basic)	95.08M	92.4M	87.56M	81.26M	77.96M	73.61M	66.25M	58.82M	48.68M
Shares Outstanding (Diluted)	107.88M	92.4M	87.56M	81.26M	77.96M	73.61M	66.25M	58.82M	48.7M
EPS (Basic)	2.47	-5.8	-8.03	-5.15	-7.11	-9.71	-5.46	-0.86	-5.49
EPS (Diluted)	2.18	-5.8	-8.03	-5.15	-7.11	-9.71	-5.46	-0.86	-5.49
EBITDA	316.89M	-439.2M	-582.12M	-306.08M	-453.38M	-652.66M	-316.66M	-34.75M	-261.12M
EBIT	279.17M	-498.09M	-636.72M	-355.42M	-493.12M	-683.21M	-328.9M	-42.83M	-266.73M
Depreciation & Amortization	37.72M	58.89M	54.6M	49.34M	39.74M	30.55M	12.24M	8.09M	5.61M